head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2024, vol. 30, issue1
Subject Area: Dental Medicine
DOI: 10.5272/jimab.2024301.5429
Published online: 20 March 2024

Original article
J of IMAB. 2024 Jan-Mar;30(1):5429-5434
Yanko Yankov1, 2ORCID logoCorresponding Autoremail, Yana Bocheva3, 4ORCID logo,
1)Department of General and Operative Surgery, Faculty of Medicine, Medical University, Varna, Bulgaria.
2)Clinic of Maxillofacial Surgery, UMHAT "St. Marina", Varna, Bulgaria.
3)Department of Clinical Laboratory, Faculty of Medicine, Medical University, Varna, Bulgaria.
4)Central clinic laboratory, UMHAT "St. Marina", Varna, Bulgaria.

Introduction: Procalcitonin (PCT) as a marker of inflammation has not been studied and analyzed in purulent inflammations of the head and neck of odontogenic origin, which is the aim of this original article.
Materials and methods: This retrospective study includes 31 men with odontogenic abscesses of the head and neck with a mean age of 42 years. As a control group, 31 healthy men are used. In all of them, leukocytes (WBC), neutrophils (Neu), C-reactive protein (CRP), and procalcitonin (PCT) are tested.
Results: The average values of the studied indicators in the patients are: CRP - 89.45±85.15 mg/l, WBC - 11.78±4.61x103/L, Neu - 8.79±4.58x103/L and PCT - 0.8±0.8 ng/ Jr. The average values of the same indicators in the control group are: CRP - 0.9±1.17 mg/l, WBC - 7.37±1.9x103/L, Neu - 4.13±1.43x103/L and PCT - 0.18±1.27 ng/ml. There is no positive correlation between PCT on the one hand and CRP, WBC and Neu on the other hand.
Discussion: The mean values of CRP, WBC, Neu and PCT are higher in men with odontogenic abscesses compared to the healthy controls, and this is statistically significant. Although PCT does not correspond to WBC, Neu and CRP, it has a number of advantages over them - it increases its concentration only in infections of bacterial origin, it increases its levels earlier and reaches its highest concentration earlier, it has a longer half-life, and its level declines more rapidly after infections.
Conclusions: All this suggests that PTC may soon become the most accurate marker in diagnosing, treating, and follow-up of patients with head and neck odontogenic abscesses.

Keywords: procalcitonin, inflammation, men, abscess, odontogenic, phlegmon, inflammatory marker, maxillofacial surgery,

pdf - Download FULL TEXT /PDF 499 KB/
Please cite this article as: Yankov Y, Bocheva Y. Procalcitonin as a New Inflammatory Marker in Odontogenic Abscesses of Head and Neck in Male Population. 2024 Jan-Mar;30(1):5429-5434. [Crossref - 10.5272/jimab.2024301.5429]

Corresponding AutorCorrespondence to: Yanko Yankov, MD, PhD, Clinic of Maxillofacial Surgery, UMHAT "Sveta Marina" EAD – Varna; 1, Hristo Smirnenski Blvd., floor 9. Varna, Bulgaria; E-mail: yanko_1989@abv.bg

1. Bertossi D, Barone A, Iurlaro A, Marconcini S, De Santis D, Finotti M, et al. Odontogenic Orofacial Infections. J Craniofac Surg. 2017 Jan;28(1):197-202. [PubMed]
2. Sanders JL, Houck RC. Dental Abscess. 2023 Feb 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. [PubMed]
3. Fusconi M, Greco A, Galli M, Polimeni A, Yusef M, Di Cianni S, et al. Odontogenic phlegmons and abscesses in relation to the financial situation of Italian families. Minerva Stomatol. 2019 Oct;68(5):236-41. [PubMed]
4. Bali RK, Sharma P, Gaba S, Kaur A, Ghanghas P. A review of complications of odontogenic infections. Natl J Maxillofac Surg. 2015 Jul-Dec;6(2):136-43. [PubMed]
5. Zawiślak E, Nowak R. Odontogenic Head and Neck Region Infections Requiring Hospitalization: An 18-Month Retrospective Analysis. Biomed Res Int. 2021 Jan 18;2021:7086763. [PubMed]
6. Julián-Jiménez A, González Del Castillo J, García-Lamberechts EJ, Huarte Sanz I, Navarro Bustos C, Rubio Díaz R, et al. A bacteraemia risk prediction model: development and validation in an emergency medicine population. Infection. 2022 Feb;50(1):203-21. [PubMed]
7. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993 Feb 27;341(8844):515-8.
8. BalcI C, Sungurtekin H, Gürses E, Sungurtekin U, Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care. 2003 Feb;7(1):85-90. [PubMed]
9. Ansari-Lari MA, Kickler TS, Borowitz MJ. Immature granulocyte measurement using the Sysmex XE-2100. Relationship to infection and sepsis. Am J Clin Pathol. 2003 Nov;120(5):795-9.
10. Möckel M, Searle J, Maisel A. The role of procalcitonin in acute heart failure patients. ESC Heart Fail. 2017 Aug;4(3):203-8. [PubMed]
11. Knudsen JB, Fuursted K, Petersen E, Wierup P, Mшlgaard H, Poulsen SH, et al. Procalcitonin in 759 patients clinically suspected of infective endocarditis. Am J Med. 2010 Dec;123(12):1121-7.
12. Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006 Jul 1;174(1):84-93.
13. Lin C, Pang Q. Meta-analysis and systematic review of procalcitonin-guided treatment in acute exacerbation of chronic obstructive pulmonary disease. Clin Respir J. 2018 Jan;12(1):10-15. [PubMed]
14. Ibrahim WH, Mushtaq K, Raza T, Kartha A, Saleh AO, Malik RA. Effects of procalcitonin-guided treatment on antibiotic use and need for mechanical ventilation in patients with acute asthma exacerbation: Meta-analysis of randomized controlled trials. Int J Infect Dis. 2017 Dec;65:75-80. [PubMed]
15. Kim H, Roh YH, Yoon SH. Blood Procalcitonin Level as a Diagnostic Marker of Pediatric Bacterial Meningitis: A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2021 May;11(5):846. [PubMed]
16. Anielski R, Kuśnierz-Cabala B, Szafraniec K. An evaluation of the utility of additional tests in the preoperative diagnostics of acute appendicitis. Langenbecks Arch Surg. 2010 Nov;395(8):1061-8. [PubMed]
17. Sand M, Trullen XV, Bechara FG, Pala XF, Sand D, Landgrafe G, et al. A prospective bicenter study investigating the diagnostic value of procalcitonin in patients with acute appendicitis. Eur Surg Res. 2009;43(3):291-7.
18. Markogiannakis H, Memos N, Messaris E, Dardamanis D, Larentzakis A, Papanikolaou D, et al. Predictive value of procalcitonin for bowel ischemia and necrosis in bowel obstruction. Surgery. 2011 Mar;149(3):394-403.
19. Pecile P, Miorin E, Romanello C, Falleti E, Valent F, Giacomuzzi F, et al. Procalcitonin: a marker of severity of acute pyelonephritis among children. Pediatrics. 2004 Aug;114(2):e249-54.
20. Zhou Q, Tan D, Yi Z, Zheng Y, Lu M. [Prognostic value of procalcitonin, endotoxin and common inflammatory markers combining MELD score in patients with chronic severe hepatitis] [in Chinese] Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Apr;38(4):388-94. [ PubMed]

Received: 23 October 2023
Published online: 20 March 2024

back to Online Journal